ZoomRx vs IOTOX Algorithm

ZoomRx is a survey platform that facilitates communication between doctors, patients, and pharmaceutical companies. The application enables patient/research organizations, pharmaceutical/biotech companies, and other survey sponsoring entities to collect information from "connected real-time panels" of patients, doctors, insurance providers, pharmacists and other stakeholders in the healthcare system. The surveys taken on ZoomRx will enhance the experience and lives of all parties involved in the health-care system by quickening the rate of information flow. The surveys on ZoomRx are designed as per guidelines issued by the Council of American Survey Research Organizations (CASRO). We adhere to the code of standards and ethics laid out by CASRO. If you have any questions on ZoomRx, please e-mail: info@zoomrx.com

Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. ​​​​​​​ Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.